Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Chicago Prostate Cancer Center (CPCC) is a world-renowned medical facility specializing in the diagnosis and treatment of prostate cancer, with a particular emphasis on advanced brachytherapy (prostate seed implantation). Founded by Dr. Brian Moran, a leading radiation oncologist and pioneer in the field, the center has performed over 10,000 brachytherapy procedures, making it one of the most experienced facilities of its kind globally. CPCC provides a comprehensive range of services, including advanced diagnostic imaging, second opinions, and various radiation treatment modalities such as IGRT and IMRT. The center is recognized for its high volume of clinical cases and its significant contributions to long-term outcome data in urologic oncology. By integrating cutting-edge technology with personalized patient care, the Chicago Prostate Cancer Center remains a primary destination for patients seeking specialized prostate cancer treatment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brian Moran Cancer Institute.